WASHINGTON, DC — Measures of liver stiffness remained stable or improved in patients with primary biliary cholangitis (PBC) after 36 months of treatment with seladelpar (Livdelzi) based on new data ...
MedPage Today: BMI and Autoimmune Liver Disease: Weight Management May Prevent Primary Biliary Cholangitis
—A recent study provides genetic evidence linking a higher body mass index (BMI) to an increased risk of primary biliary cholangitis and autoimmune hepatitis but a decreased risk of primary sclerosing ...
BMI and Autoimmune Liver Disease: Weight Management May Prevent Primary Biliary Cholangitis
Primary Biliary Cholangitis: Causes, Symptoms, Diagnosis and Treatment: By Shreoshree Chakrabarty Primary biliary cholangitis (PBC) is a chronic liver disease that gradually damages the bile ducts ...
Primary biliary cholangitis (PBC) is a chronic cholestatic disorder in which symptoms exert a direct influence on patients’ quality of life. Beyond pruritus and fatigue, patients with PBC are also ...
News Medical: Blood group A linked to a higher risk of primary biliary cholangitis
A major retrospective study shows that people with blood group A face a higher likelihood of autoimmune liver disease, especially primary biliary cholangitis, while those with blood group B appear ...
Blood group A linked to a higher risk of primary biliary cholangitis
Seeking Alpha: Gilead’s Livdelzi® Demonstrates Sustained Efficacy in Primary Biliary Cholangitis (PBC), Offering Alkaline Phosphatase (ALP) Reduction, Itch Relief and Potential to Slow ...
Gilead Sciences, Inc. today announced new long-term data reinforcing the safety and efficacy profile of Livdelzi ® for people living with primary biliary cholangitis. These findings were presented at ...
Gilead’s Livdelzi® Demonstrates Sustained Efficacy in Primary Biliary Cholangitis (PBC), Offering Alkaline Phosphatase (ALP) Reduction, Itch Relief and Potential to Slow ...